Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Opko Health, a specialty healthcare company involved in the discovery, development and commercialisation of proprietary pharmaceutical and diagnostic products and vaccines, has signed a letter of intent to collaborate with the Centro de Investigacion y Asistencia Tecnologica y Diseno del Estado de Jalisco (CIATEJ), a technology and research center in the State of Jalisco, Mexico.
Subscribe to our email newsletter
Under the collaboration, the organisations intend to initially develop and manufacture vaccines for flu, dengue fever and West Nile virus.
Phillip Frost, chairman and CEO of Opko, said: “This initial step to develop a long and productive relationship with CIATEJ follows our purchase of Pharmacos Exacta, with offices and manufacturing facilities in Guadalajara, Mexico.
“The acquisition of Exakta and our collaboration with CIATEJ furthers our strategy of expanding commercial activities while we continue to develop important therapeutic and diagnostic products.”